Program Details
Intended Audience: Pharmacists
Contact Hours: This program has been approved by the Accreditation Council for Pharmacy Education for 3.75 hours of continuing pharmacy education credit.
Program Fees:
In-Person Registration Fee:
General Registration (Early Bird) – $210
General Registration (Full Price) – $300
Student Registration (Early Bird) – $90
Student Registration (Full Price) – $120
Virtual Registration Fee:
General Registration – $120
Student Registration – $60
Program Support: No outside financial support was provided.
Objectives
At the completion of this activity, the participant will be able to:
- Summarize current evidence regarding cumulative cannabis exposures and cognitive outcomes
- Review evidence regarding in utero cannabis exposures on neurodevelopmental outcomes
- Interpret clinical recommendations regarding opioid and cannabis concomitant use
Speakers
A) Session Title: Recreational and Medical Cannabis: Potential Implications on Cognition and Clinical Outcomes (1.25 credit hour)
Speaker: Jodi Gilman, PhD
Director of Neuroscience, Center for Addiction Medicine, Massachusetts General Hospital
Associate Professor, Dept. of Psychiatry, Harvard Medical School
B) Session Title: Cannabis Use During Pregnancy: Research from Policy to Practice (1.25 credit hour)
Speaker: Kelly Young-Wolff, PhD, MPH
Adjunct Associate Professor, Dept. of Psychiatry, UC San Francisco
Consulting Assistant Professor, School of Medicine, Stanford University
Associate Professor, Bernard J. Tyson School of Medicine, Kaiser Permanente
Clinical Psychologist and Research Scientist, Northern California Division of Research, Kaiser Permanente
C) Session Title: Opioid and Cannabinoid Interactions: Abuse Potential and Clinical Implications (1.25 credit hour)
Speaker: Shanna Babalonis, PhD
Director, Cannabis Center, University of Kentucky
Assistant Professor, Dept. of Behavioral Science and Center on Drug and Alcohol Research, University of Kentucky
Schedule of Educational Activities
Time (EDT) | Session Description ∆=Virtual option available |
9:00-9:20am | Day 1 Welcome Address# Δ
|
9:20-9:30am | Agenda Overview and Introduction to Keynote# Δ |
9:30-10:45am | Keynote: Recreational and Medical Cannabis: Potential Implications on Cognition and Clinical Outcomes* Δ
|
10:45-11:00am | Exhibitor Hall | Coffee Break |
11:00-12:00pm | Presentations of Top Abstracts w/ Q&A#
|
12:00-1:00pm | Lunch |
1:00-2:15pm | Keynote: Cannabis Use During Pregnancy: Research from Policy to Practice* Δ
|
2:15-3:30pm | Poster Session 1 | Exhibitor Hall | Coffee Break |
3:30-4:15pm | Clinical Challenges in Medical Cannabis Practice#
|
4:15-5:00pm | Note: Sessions A & B Will Be Held Simultaneously |
Session A: The Medical Marijuana & Me (M3) Study overview and findings from the cross-sectional survey of Florida medical marijuana patients#
| |
Session B: Using Contemporary Communication Approaches to Educate Athletes About Marijuana#
| |
5:00-6:30pm | Poster Session 2 | Exhibitor Hall | Networking Reception |
Time (EDT) | Session Description ∆=Virtual option available |
8:00-8:15am | Day 2 Welcome Address# Δ
|
8:15-9:30am | Keynote: Opioid and Cannabinoid Interactions: Abuse Potential and Clinical Implications* Δ
|
9:30-10:30am | Presentations of Top Abstracts w/ Q&A# Bassma Eltanameli |
10:30-10:45am | Exhibitor Hall | Coffee Break |
10:45-11:30am | Note: Sessions A & B Will Be Held Simultaneously |
Session A: Using a hemp pathway to probe the entourage effect. What other questions can be answered using this regulatory pathway?# Dr. Anthony Ferrari | Dr. Jeff Konin | |
Session B: Role of Exosomes containing CBD in cancer and chemotherapy induced peripheral neuropathy# Dr. Mandip Sachdeva | |
11:30-12:00pm | Closing and Awards Ceremony# Δ |
12:00-1:00pm | Board Meeting and Invited Lunch Reception |
Requirements for Successful Course Completion
To receive continuing education credit, participants must attend all sessions accredited for CPE and complete an online program evaluation for the day(s) attended. Partial credit will not be awarded to participants not in attendance for all accredited sessions on the day credit is claimed.
Disclosure Statement
Keynote speaker Shanna Bablonis, PhD has disclosed she was a consultant for Canopy Growth Corporation. Planning committee member Almut Winterstein, R.Ph., Ph.D. has disclosed that she receives research support from Merck and Sharpe & Dohme, and was a consultant for Arbor Pharmaceuticals, Bayer, Genentech, Inc., and Ipsen. No one else in a position to control content has any financial relationships to disclose.
The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.